Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Lizak, Nathaniel; Lugaresi, Alessandra; Alroughani, Raed; Lechner-Scott, Jeannette; Slee, Mark; Havrdova, Eva; Horakova, Dana; Trojano, Maria; Izquierdo, Guillermo; Duquette, Pierre; Girard, Marc; Prat, Alexandre; Grammond, Pierre; Hupperts, Raymond; Grand'Maison, Francois; Sola, Patrizia; Pucci, Eugenio; Bergamaschi, Roberto; Oreja-Guevara, Celia; Van Pesch, Vincent; Ramo, Cristina; Spitaleri, Daniele; Iuliano, Gerardo; BOZ, CAVİT; Granella, Franco; Olascoaga, Javier; Verheul, Freek; Rozsa, Csilla; Cristiano, Edgardo; Flechter, Shlomo; Hodgkinson, Suzanne; Amato, Maria; Deri, Norma; Jokubaitis, Vilija; Spelman, Tim; Butzkueven, Helmut; Kalincik, Tomas

doi:10.1136/jnnp-2016-313976

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

Atıf İçin Kopyala

Lizak N., Lugaresi A., Alroughani R., Lechner-Scott J., Slee M., Havrdova E., ...Daha Fazla

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, cilt.88, sa.3, ss.196-203, 2017 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 88 Sayı: 3
Basım Tarihi: 2017
Doi Numarası: 10.1136/jnnp-2016-313976
Dergi Adı: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.196-203
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Objective To evaluate variability and predictability of disability trajectories in moderately advanced and advanced multiple sclerosis (MS), and their modifiability with immunomodulatory therapy.